GWM
VRSN icon

Geneos Wealth Management’s VeriSign VRSN Stock Holding History

Geneos Wealth Management’s Portfolio VRSN Stock Details VRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173K Sell
697
-59
-8% -$14K ﹤0.01% 1008
2025
Q4 		$184K Buy
756
+718
+1,889% +$180K ﹤0.01% 951
2025
Q3 		$10.6K Sell
38
-82
-68% -$22.9K ﹤0.01% 1945
2025
Q2 		$34.7K Sell
120
-143
-54% -$38.7K ﹤0.01% 1758
2025
Q1 		$66.8K Buy
263
+188
+251% +$42.7K ﹤0.01% 1772
2024
Q4 		$15.5K Sell
75
-12
-14% -$2.26K ﹤0.01% 1846
2024
Q3 		$16.5K Buy
87
+81
+1,350% +$14.6K ﹤0.01% 1632
2024
Q2 		$1.07K Hold
6
– – ﹤0.01% 1972
2024
Q1 		$1.14K Hold
6
– – ﹤0.01% 1993
2023
Q4 		$1.24K Buy
+6
New +$1.25K ﹤0.01% 1987
2022
Q2 		– Sell
-88
Closed -$19K – 2803
2022
Q1 		$19K Sell
88
-289
-77% -$63K ﹤0.01% 1837
2021
Q4 		$95K Buy
377
+300
+390% +$69.4K ﹤0.01% 1194
2021
Q3 		$15K Hold
77
– – ﹤0.01% 2078
2021
Q2 		$17K Hold
77
– – ﹤0.01% 2001
2021
Q1 		$16K Sell
77
-2,009
-96% -$395K ﹤0.01% 2188
2020
Q4 		$416K Buy
2,086
+830
+66% +$170K 0.02% 587
2020
Q3 		$258K Sell
1,256
-115
-8% -$23.8K 0.01% 602
2020
Q2 		$279K Buy
1,371
+216
+19% +$44.8K 0.02% 567
2020
Q1 		$200K Buy
1,155
+871
+307% +$171K 0.01% 610
2019
Q4 		$55K Buy
284
+254
+847% +$47.7K ﹤0.01% 1207
2019
Q3 		$5K Hold
30
– – ﹤0.01% 2119
2019
Q2 		$6K Hold
30
– – ﹤0.01% 2091
2019
Q1 		$5K Hold
30
– – ﹤0.01% 2060
2018
Q4 		$4K Hold
30
– – ﹤0.01% 2076
2018
Q3 		$4K Hold
30
– – ﹤0.01% 2138
2018
Q2 		$4K Hold
30
– – ﹤0.01% 2001
2018
Q1 		$3K Hold
30
– – ﹤0.01% 1977
2017
Q4 		$3K Buy
+30
New +$3.35K ﹤0.01% 1965
2017
Q3 		– Sell
-17
Closed -$1K – 2156
2017
Q2 		$1K Buy
+17
New +$1.53K ﹤0.01% 2036

Other funds holding VRSN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Geneos Wealth Management's VRSN Position: Q1 2026 in Review

Geneos Wealth Management reduced its VeriSign (VRSN) stake by 7.8% in Q1 2026, selling an estimated $14K and leaving 697 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

Geneos Wealth Management first reported a position in VRSN in Q2 2017 and has held it in 29 quarters since. The position peaked at $416K in Q4 2020. 846 funds tracked by Wall St. Rank hold VRSN as of Q1 2026.

  • Geneos Wealth Management held 697 shares of VeriSign worth $173K as of Q1 2026.
  • Geneos Wealth Management sold 59 VeriSign shares in Q1 2026, an estimated $14K.
  • VeriSign made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1008 holding.
  • Geneos Wealth Management first reported a position in VeriSign in Q2 2017 and has held it in 29 quarters since.
  • Geneos Wealth Management's VeriSign position peaked at $416K in Q4 2020.
  • 846 funds tracked by Wall St. Rank held VeriSign as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.